Executives
Douglas J. Batdorff Appointed New Vice President of Kewaunee Scientific Manufacturing Operations
Mr. Batdorff will have responsibility for all of Kewaunee's domestic manufacturing operations.
Executives
Dr. Gil Kliman and Tom Frinzi Appointed to STAAR Surgical Board of Directors
The appointment of Dr. Gil Kliman and Tom Frinzi brings the total number of members on STAAR's Board to six.
Executives
TriSalus Appoints Rajesh B. Mistry Chief Financial Officer
Mr. Mistry joins TriSalus with a wide spectrum of healthcare experience, spanning pharmaceuticals, biotech, medical devices, and healthcare services.
Executives
Dr. Vera Bittner Named Editor-in-Chief of ACCSAP
As editor, Bittner will lead the program’s development by working with the editorial board and editors of comparable programs to create and maintain content development standards and ensure desired content objectives.
Executives
Rosemarie Tully Appointed COO of Neuromod Devices Limited
Rosemarie Tully most recently held the role of Chief Business Officer, responsible for business development, corporate, and commercial strategy.
Executives
Dr. Catherine Y. Spong New Editor-in-Chief of Contemporary OB/GYN®
Dr. Spong is a professor and vice-chair in the department of obstetrics and gynecology at The University of Texas Southwestern Medical Center, where she also serves as the chief of the department’s division of maternal-fetal medicine.
Executives
MedX Health Corp. Appoints Veteran Healthcare Industry Executive Damon Goodwin as Global Director of Sales
Damon Goodwin will play an integral part in MedX’s revenue growth by building global partnerships for MedX’s skin assessment telemedicine technology. Initially supporting the roll out and expansions in Mexico, Brazil and the USA, he will also be responsible for securing joint ventures & partnerships around the world.
Executives
Sean Saint, Co-Founder and CEO of Companion Medical Named One of the Top 50 Healthcare Technology CEOs of 2020
"I never really intended to start Companion Medical. After I was diagnosed with Type 1 in 2011, I started doing the research and realized that there were no other companies providing advanced technology and insulin intelligence to the millions of people with diabetes who decide not to be tethered to an insulin pump," said Saint.
